Statistics

Total Visits

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib86

Select a period of time:

Number of views in the range

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib24

Views

Views
November 20251
December 20252
January 20262
February 20260
March 20267
April 20269
May 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Switzerland1
Germany1
Spain1
France1
United Kingdom1
Netherlands1
Turkey1
 

Top cities views

Views
Santa Clara2
Ashburn2
Ankara1
Annapolis1
Chattanooga1
Frankfurt am Main1
Hoofddorp1
Knoxville1
Madrid1